BioCentury
ARTICLE | Clinical News

Ampion: Phase III data

July 11, 2016 7:00 AM UTC

Top-line data from the double-blind, U.S. Phase III PIVOT trial in 480 patients with pain due to OA of the knee showed that a single 4 mL intra-articular injection of Ampion missed the primary endpoin...